Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Atypical myeloproliferative disorders in adults.

Zachée P.

Transfus Apher Sci. 2011 Apr;44(2):211-21. doi: 10.1016/j.transci.2011.01.017. Review.

PMID:
21402312
2.

Atypical myeloproliferative disorders: diagnosis and management.

Tefferi A, Elliott MA, Pardanani A.

Mayo Clin Proc. 2006 Apr;81(4):553-63. Review.

PMID:
16610578
3.

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.

Tefferi A, Skoda R, Vardiman JW.

Nat Rev Clin Oncol. 2009 Nov;6(11):627-37. doi: 10.1038/nrclinonc.2009.149. Epub 2009 Oct 6. Review.

PMID:
19806146
4.

Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.

Valent P, Sperr WR, Samorapoompichit P, Geissler K, Lechner K, Horny HP, Bennett JM.

Leuk Res. 2001 Jul;25(7):595-602. Review.

PMID:
11377685
5.
6.

Clinical applications of molecular haematology: an overview.

Bain BJ.

J Assoc Physicians India. 2007 Jul;55:503-6. Review.

PMID:
17907501
7.

Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.

Hall J, Foucar K.

Int J Lab Hematol. 2010 Dec;32(6 Pt 2):559-71. doi: 10.1111/j.1751-553X.2010.01251.x. Review.

PMID:
20670271
8.

The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos.

Tefferi A, Thiele J, Vardiman JW.

Cancer. 2009 Sep 1;115(17):3842-7. doi: 10.1002/cncr.24440.

9.

[Mastocytosis and eosinophilic leukemia: diagnostics and classification].

Sotlar K, Valent P, Horny HP.

Pathologe. 2012 Nov;33(6):539-52. doi: 10.1007/s00292-012-1654-0. German.

PMID:
23085697
10.

Philadelphia chromosome-negative chronic myeloproliferative disease.

Thiele J.

Am J Clin Pathol. 2009 Aug;132(2):261-80. doi: 10.1309/AJCPR8GINMBDG9YG. Review.

11.
12.

Primary eosinophilic disorders: a concise review.

Pardanani A, Tefferi A.

Curr Hematol Malig Rep. 2008 Jan;3(1):37-43. doi: 10.1007/s11899-008-0007-9. Review.

PMID:
20425445
13.

Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.

Jordan JH, Jäger E, Sperr WR, Schwarzinger I, Födinger M, Fritsche-Polanz R, Ohler L, Geissler K, Valent P.

Eur J Clin Invest. 2003 Jul;33(7):611-8.

PMID:
12814399
14.

Oncogenes in myeloproliferative disorders.

Tefferi A, Gilliland DG.

Cell Cycle. 2007 Mar 1;6(5):550-66. Epub 2007 Mar 24. Review.

PMID:
17351342
15.

Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders.

Horny HP, Ruck M, Wehrmann M, Kaiserling E.

Br J Haematol. 1990 Oct;76(2):186-93.

PMID:
2128807
17.

Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome.

Bain BJ, Fletcher SH.

Immunol Allergy Clin North Am. 2007 Aug;27(3):377-88. Review.

PMID:
17868855
18.

Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis.

Tefferi A, Pardanani A.

Int J Hematol. 2004 Jun;79(5):441-7. Review.

PMID:
15239393
19.

The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.

Orazi A, Germing U.

Leukemia. 2008 Jul;22(7):1308-19. doi: 10.1038/leu.2008.119. Epub 2008 May 15. Review.

PMID:
18480833
20.

Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies.

Pardanani A, Lim KH, Lasho TL, Finke C, McClure RF, Li CY, Tefferi A.

Blood. 2009 Oct 29;114(18):3769-72. doi: 10.1182/blood-2009-05-220145. Epub 2009 Aug 27.

Items per page

Supplemental Content

Write to the Help Desk